Trials / Completed
CompletedNCT00399542
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Phase 3, 12-Week, Multicenter, Double-Blind, Randomized, Efficacy and Safety Study of Lubiprostone for the Treatment of Irritable Bowel Syndrome With Constipation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 581 (actual)
- Sponsor
- Sucampo Pharma Americas, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lubiprostone | |
| DRUG | Placebo |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2006-11-15
- Last updated
- 2019-12-17
- Results posted
- 2008-10-31
Source: ClinicalTrials.gov record NCT00399542. Inclusion in this directory is not an endorsement.